Literature DB >> 32827759

Menstrual Dysfunction and Treatment Among Adolescents With Congenital Heart Disease.

Maayan Leroy-Melamed1, Amy Katz2, Marcia L Shew2.   

Abstract

STUDY
OBJECTIVE: This study describes menstrual dysfunction and treatment among adolescent and young adult (AYA) females with congenital heart disease (CHD).
DESIGN: Data collected from a 1-time survey completed by AYA females (and mothers if AYA unable).
SETTING: Participants were recruited from pediatric cardiology clinics. PARTICIPANTS: Female AYA with CHD, aged 14-21 years (N = 114).
INTERVENTIONS: None. MAIN OUTCOME MEASURES: The questionnaire assessed sexual and reproductive health (SRH) concerns, behaviors, and management. Outcome measures were self-reported menstrual complaints, use of over-the-counter (OTC) pain relief medications for dysmenorrhea, reported visits with a clinician for a menstrual problem, and reported use of hormones for menstrual problems or birth control.
RESULTS: Mean age was 17.0 years (SD = 2.2). The majority of participants (83%) reported 1 or more menstrual complaints (67.5% cramping, 42.1% irregular menses, 46.5% heavy periods), and 88% reported any history of taking OTC medications for pain relief. Increased menstrual complaints were not associated with level of cardiac complexity, reported transplantation, or reported use of hormonal contraception. However, 32% of participants reported use of hormonal contraception for menstrual dysfunction. Combined oral contraceptive pills (COCs) were the most common; 2 of these women carried contraindications to estrogen.
CONCLUSIONS: A large majority of AYA females with CHD reported menstrual dysfunction. Use of OTC medication for menstrual pain and inappropriate use of estrogen creates concerns that menstrual disorders may be unaddressed or addressed inappropriately. Thus, gynecological needs of adolescents with CHD may need to be specifically targeted by providers who feel comfortable with this population and their complex needs.
Copyright © 2020 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular abnormalities; Contraindications; Menstruation disturbances

Mesh:

Substances:

Year:  2020        PMID: 32827759      PMCID: PMC9134926          DOI: 10.1016/j.jpag.2020.08.012

Source DB:  PubMed          Journal:  J Pediatr Adolesc Gynecol        ISSN: 1083-3188            Impact factor:   2.046


  30 in total

Review 1.  Choosing the best contraceptive method for the adult with congenital heart disease.

Authors:  Candice K Silversides; Mathew Sermer; Samuel C Siu
Journal:  Curr Cardiol Rep       Date:  2009-07       Impact factor: 2.931

2.  Combined hormonal contraception use in reproductive-age women with contraindications to estrogen use.

Authors:  Julianne R Lauring; Erik B Lehman; Timothy A Deimling; Richard S Legro; Cynthia H Chuang
Journal:  Am J Obstet Gynecol       Date:  2016-04-05       Impact factor: 8.661

3.  Congenital heart disease in the adolescent.

Authors:  J Somerville
Journal:  Arch Dis Child       Date:  1989-06       Impact factor: 3.791

4.  Menstrual patterns in adolescent Swiss girls: a longitudinal study.

Authors:  D Flug; R H Largo; A Prader
Journal:  Ann Hum Biol       Date:  1984 Nov-Dec       Impact factor: 1.533

Review 5.  Gynecologic and obstetric issues in the adolescent with heart disease.

Authors:  M A Mendelson
Journal:  Adolesc Med       Date:  2001-02

6.  U S. Medical Eligibility Criteria for Contraceptive Use, 2010.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2010-06-18

Review 7.  Sexual and reproductive health in young people with congenital heart disease: a systematic review of the literature.

Authors:  A Hargrove; D J Penny; S M Sawyer
Journal:  Pediatr Cardiol       Date:  2005 Nov-Dec       Impact factor: 1.655

8.  U.S. Medical Eligibility Criteria for Contraceptive Use, 2016.

Authors:  Kathryn M Curtis; Naomi K Tepper; Tara C Jatlaoui; Erin Berry-Bibee; Leah G Horton; Lauren B Zapata; Katharine B Simmons; H Pamela Pagano; Denise J Jamieson; Maura K Whiteman
Journal:  MMWR Recomm Rep       Date:  2016-07-29

Review 9.  Reproductive Health and Women With Congenital Heart Disease: A Practice Update.

Authors:  Kathryn A Osteen; Claudia C Beal
Journal:  J Perinat Neonatal Nurs       Date:  2016 Jan-Mar       Impact factor: 1.638

10.  Counseling reproductive health issues in women with congenital heart disease.

Authors:  Mathias Kaemmerer; Matthäus Vigl; Vanadin Seifert-Klauss; Nicole Nagdyman; Ulrike Bauer; Karl-Theo Maria Schneider; Harald Kaemmerer
Journal:  Clin Res Cardiol       Date:  2012-05-15       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.